KMS Medisurgi Limited has formally notified BSE Limited of its exemption from corporate governance reporting requirements under SEBI regulations. The company cites Regulation 15(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which exempts certain categories of listed entities from compliance with specific corporate governance provisions.
The exemption applies to two categories: (a) listed entities with paid-up equity share capital not exceeding ₹10 crore and net worth not exceeding ₹25 crore as of the last day of the previous financial year, and (b) listed entities that have listed their specified securities on the SME Exchange.
As KMS Medisurgi Limited has listed its shares on the BSE SME Platform, the company confirms that the corporate governance reporting requirements under Regulation 27(2) do not apply for the quarter ended 30th September, 2026. The company specifically references that provisions under regulations 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26, 27 and certain clauses of regulation 46 and Schedule V are not applicable.
Financial Impact
No financial impact disclosed. This is a regulatory compliance exemption notification.